6733
博晟生醫
-0.40 (-1.57%)25.1579成交張數–本益比3.16股價淨值比0.00%殖利率2026-09-11資料日期
每股盈餘
柱為單季 EPS,線為近四季合計;近十年
| 季度 | 單季 EPS | 年增 | 近四季 EPS | 歸屬母公司淨利(億) | 淨利率 | ROE(季) | ROE(近四季) |
|---|---|---|---|---|---|---|---|
| 2026Q2 | -0.18 | – | -0.54 | -0.24 | -40.2% | -2.22% | -7.41% |
| 2026Q1 | -0.13 | – | -0.55 | -0.16 | -28.7% | -1.72% | -7.16% |
| 2025Q4 | -0.18 | – | -0.69 | -0.21 | -35.1% | -2.83% | -10.85% |
| 2025Q3 | -0.05 | – | -0.83 | -0.07 | -11.1% | -0.90% | -12.52% |
| 2025Q2 | -0.19 | – | -1.04 | -0.23 | -44.0% | -2.99% | -15.22% |
| 2025Q1 | -0.27 | – | -1.13 | -0.33 | -70.1% | -4.15% | -16.15% |
| 2024Q4 | -0.32 | – | -0.95 | -0.39 | -77.6% | -4.63% | -13.25% |
| 2024Q3 | -0.26 | – | -0.89 | -0.31 | -70.9% | -3.52% | -11.89% |
| 2024Q2 | -0.28 | – | -0.98 | -0.35 | -93.6% | -3.80% | -12.58% |
| 2024Q1 | -0.09 | – | -0.93 | -0.11 | -30.8% | -1.17% | -11.71% |
| 2023Q4 | -0.26 | – | -1.30 | -0.33 | -82.7% | -3.42% | -19.02% |
| 2023Q3 | -0.35 | – | -1.57 | -0.42 | -201.2% | -4.26% | -20.51% |
| 2023Q2 | -0.23 | – | -1.72 | -0.30 | -78.1% | -2.90% | -20.50% |
| 2023Q1 | -0.46 | – | -1.82 | -0.51 | -473.7% | -5.84% | -20.19% |
| 2022Q4 | -0.54 | – | -1.78 | -0.53 | -484.9% | -7.33% | -23.20% |
| 2022Q3 | -0.49 | – | -1.38 | -0.52 | -543.9% | -6.69% | -17.92% |
| 2022Q2 | -0.33 | – | -1.26 | -0.34 | -582.9% | -4.19% | -15.47% |
| 2022Q1 | -0.42 | – | -1.30 | -0.45 | -898.0% | -5.16% | -15.24% |
| 2021Q4 | -0.14 | – | -1.34 | -0.14 | -294.3% | -1.61% | – |
| 2021Q3 | -0.37 | – | – | -0.39 | -1939.6% | -4.41% | – |
| 2021Q2 | -0.37 | – | – | -0.38 | -2834.4% | -4.12% | – |
| 2021Q1 | -0.46 | – | – | -0.47 | -4304.6% | – | – |